The Impact of Self Reminder Interactive (SRI) Application on Quality of Life, Compliance of anti-TB Drug, and Self Efficacy Among TB Patients
DOI:
https://doi.org/10.53770/amhj.v3i4.245Keywords:
SRI (Self Reminder Interactive) Application, Anti-TB drug adherence, Self-Efficacy, Quality of Life, Pulmonary TBAbstract
The impact of technology plays a significant role in health, including prevention and rehabilitation of Tuberculosis patients. One of the breakthroughs made to reduce pulmonary tuberculosis sufferers is through telenursing to improve patient behavior in preventing transmission of pulmonary tuberculosis. This study aimed to identify the influence of the Community Resources-based SRI (Self Reminder Interaction) Application on improving the quality of life, anti-TB drug Compliance, and Self-Efficacy among Pulmonary Tuberculosis patients. This study is a quasi-experiment research type with a nonequivalent control pre-test and post-test design. The sample in this study was selected using simple random sampling with a total of 50 respondents. The independent variables of this study were SRI application implementation, then the dependent variables included quality of life, self-efficacy, and anti-TB drug adherence. The results of this study consist of the majority of respondents were aged 35 to 39 years old, female, and working as private laborers. The bivariate results found the significant impact of SRI application to increase quality of life, self-efficacy, and anti-TB drug adherence after. Among case groups, there is found significant improvement between pre and post-test after giving intervention. It can be concluded that the SRI application is significant in improving TB patient life. Future studies could add more predictors related to the accessibility of technology such as education level, income, and place of residence to explore the impact of such application in multivariate analysis.
References
Abaynew, Y., Ahmed, A., Taye, G., & Shenkut, M. (2023). Prevalence and Types of Anemia Among People With Tuberculosis in Africa: A Systematic Review and Meta-Analysis. Scientific Reports. https://doi.org/10.1038/s41598-023-32609-1
Alene, K. A., Viney, K., Moore, H. C., Wagaw, M., & Clements, A. C. A. (2019). Spatial Patterns of Tuberculosis and HIV Co-Infection in Ethiopia. Plos One. https://doi.org/10.1371/journal.pone.0226127
Alkabab, Y., Warkentin, J., Cummins, J., Katz, B. Z., Denison, B. M., Bartok, A., Khalil, A., Young, L. R., Timme, E., Peloquin, C. A., Ashkin, D., Houpt, E. R., & Heysell, S. K. (2023). Therapeutic Drug Monitoring and TB Treatment Outcomes in Patients With Diabetes Mellitus. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.22.0448
Amer, F. A., Mohamed, M. S., Elbur, A. I., Abdelaziz, S. I., & Elrayah, Z. A. B. (2018). Influence of Self-Efficacy Management on Adherence to Self-Care Activities and Treatment Outcome Among Diabetes Mellitus Type 2 Sudanese Patients. Pharmacy Practice. https://doi.org/10.18549/pharmpract.2018.04.1274
Apriani, L., McAllister, S., Sharples, K., Aini, I. N., Nurhasanah, H., Ruslami, R., Menzies, D., Hill, P. C., & Alisjahbana, B. (2022). Mycobacterium Tuberculosis Infection and Disease in Healthcare Workers in a Tertiary Referral Hospital in Bandung, Indonesia. Journal of Infection Prevention. https://doi.org/10.1177/17571774211046887
Arsenault, C., Roder-DeWan, S., & Kruk, M. E. (2019). Measuring and Improving the Quality of Tuberculosis Care: A Framework and Implications From the Lancet Global Health Commission. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. https://doi.org/10.1016/j.jctube.2019.100112
Assiana, D. O. E., Abdul, J. B. P. A. A., Linguissi, L. S. G., Epola, M., Vouvoungui, C., Mabiala, A., Biyogho, C. M., Edoa, J. R., Adegbite, B. R., Adegnika, A. A., Elton, L., Canseco, J. O., McHugh, T. D., Ahombo, G., & Ntoumi, F. (2021). Epidemiological Profile of Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium Tuberculosis Among Congolese Patients. Annals of Clinical Microbiology and Antimicrobials. https://doi.org/10.1186/s12941-021-00488-x
Bagcchi, S. (2023). WHO’s global tuberculosis report 2022. The Lancet Microbe, 4(1), e20.
Baya, B., Achenbach, C., Kone, B., Toloba, Y., Dabitao, D., Diarra, B., Goita, D., Diabate, S., Maiga, M., Soumaré, D., Ouattara, K., Kanouté, T., Berthé, G., Kamia, Y. M., Sarro, Y. d. S., Sanogo, M., Togo, A., Dembele, B. P., Coulibaly, N., … Diallo, S. (2019). Clinical Risk Factors Associated With Multidrug-Resistant Tuberculosis (MDR-TB) in Mali. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2019.02.004
Bifftu, B. B., Tiruneh, B. T., Guracho, Y. D., & Dachew, B. A. (2019). Prevalence of Depressive Symptoms and Associated Factors Among People With Tuberculosis in Ethiopia: Meta-Analysis. https://doi.org/10.21203/rs.2.17054/v1
Couvin, D., Reynaud, Y., & Rastogi, N. (2019). Two Tales: Worldwide Distribution of Central Asian (CAS) Versus Ancestral East-African Indian (EAI) Lineages of Mycobacterium Tuberculosis Underlines a Remarkable Cleavage for Phylogeographical, Epidemiological and Demographical Characteristics. Plos One. https://doi.org/10.1371/journal.pone.0219706
Desissa, F., Workineh, T., & Beyene, A. S. (2018). Risk Factors for the Occurrence of Multidrug-Resistant Tuberculosis Among Patients Undergoing Multidrug-Resistant Tuberculosis Treatment in East Shoa, Ethiopia. BMC Public Health. https://doi.org/10.1186/s12889-018-5371-3
Elduma, A. H., Mansournia, M. A., Foroushani, A. R., Ali, H. M. H., Asrar, M., Elegail, S., Elsony, A., & Holakouie-Naieni, K. (2019). Assessment of the Risk Factors Associated With Multidrug-Resistant Tuberculosis in Sudan: A Case-Control Study. Epidemiology and Health. https://doi.org/10.4178/epih.e2019014
England, K., Masini, T., & Fajardo, E. (2019). Detecting Tuberculosis: Rapid Tools but Slow Progress. Public Health Action. https://doi.org/10.5588/pha.19.0013
Faraade, M. H., Jeffree, M. S., Lin, L., Fiidow, O. A., Avoi, R., PASUPULETI, V. R., & Hassan, M. R. (2022). Intervention Approaches of Stigma Related to Tuberculosis in Developing Countries: A Systematic Review. Malaysian Journal of Public Health Medicine. https://doi.org/10.37268/mjphm/vol.22/no.2/art.1753
Hirsch-Moverman, Y., Mantell, J. E., Lebelo, L., Howard, A. A., Hesseling, A. C., Nachman, S., Frederix, K., Maama, L. B., & El-Sadr, W. (2020). Provider Attitudes About Childhood Tuberculosis Prevention in Lesotho: A Qualitative Study. BMC Health Services Research. https://doi.org/10.1186/s12913-020-05324-0
Isnainy, U. C. (2021). Self-Efficacy With the Quality of Life of Pulmonary Tb Patients. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v16i1.17609
Izhar, M. D., Butar, M. B., Hidayati, F., & Ruwayda, R. (2021). Predictors and Health-Related Quality of Life With Short Form-36 for Multidrug-Resistant Tuberculosis Patients in Jambi, Indonesia: A Case-Control Study. Clinical Epidemiology and Global Health. https://doi.org/10.1016/j.cegh.2021.100872
Kersten, J. F., Nienhaus, A., Schneider, S., & Schablon, A. (2020). Tuberculosis Among Health Workers—A Secondary Data Analysis of German Social Accident Insurance Data From 2002–2017. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph17051564
Ksatriaputra, A., Kholis, F. N., Ngestiningsih, D., & Hariyana, B. (2020). Quality of Life Among Tuberculosis Patients With and Without Diabetes Mellitus Before and After Anti-Tb Drugs Administration. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal). https://doi.org/10.14710/dmj.v9i6.29334
Li, H., Wu, Q., Hu, J., Liang, F., Wu, Q., Heng, Y., Li, L., & Li, X. (2021). Application of Loop-Mediated Isothermal Amplification and Next-Generation Sequencing in the Diagnosis of Maternal Tuberculosis With Multiple Negative Tests. Medicine. https://doi.org/10.1097/md.0000000000027387
Li, X., Pang, X., & Zhang, F. (2022). Evaluation of Mobile Application for the Management of Tuberculosis Patients in Tianjin During 2019–2020. Patient Preference and Adherence. https://doi.org/10.2147/ppa.s321289
Maja, T. F., & Maposa, D. (2022). An Investigation of Risk Factors Associated With Tuberculosis Transmission in South Africa Using Logistic Regression Model. Infectious Disease Reports. https://doi.org/10.3390/idr14040066
Majigo, M., Somi, G., Joachim, A., Manyahi, J., Nondi, J., Sambu, V., Rwebembera, A., Makyao, N., Ramadhani, A., Maokola, W., Todd, J., & Matee, M. (2020). Prevalence and Incidence Rate of Tuberculosis Among HIV-infected Patients Enrolled in HIV Care, Treatment, and Support Program in Mainland Tanzania. Tropical Medicine and Health. https://doi.org/10.1186/s41182-020-00264-1
Manyazewal, T., Woldeamanuel, Y., Holland, D., Fekadu, A., Blumberg, H. M., & Marconi, V. C. (2020). Electronic Pillbox-Enabled Self-Administered Therapy Versus Standard Directly Observed Therapy for Tuberculosis Medication Adherence and Treatment Outcomes in Ethiopia (SELFTB): Protocol for a Multicenter Randomized Controlled Trial. Trials. https://doi.org/10.1186/s13063-020-04324-z
Moonan, P. K., Nair, S. A., Agarwal, R., Chadha, V. K., Dewan, P., Gupta, U. D., Ho, C., Holtz, T. H., Kumar, A. M. V, Kumar, N., Kumar, P., Maloney, S. A., Mase, S., Oeltmann, J. E., Paramasivan, C. N., Parmar, M., Rade, K., Ramachandran, R., Rao, R., … Khaparde, S. (2018). Tuberculosis Preventive Treatment: The Next Chapter of Tuberculosis Elimination in India. BMJ Global Health. https://doi.org/10.1136/bmjgh-2018-001135
Musiimenta, A., Tumuhimbise, W., Atukunda, E. C., Mugaba, A. T., Muzoora, C., Armstrong-Hough, M., Bangsberg, D. R., Davis, J. L., & Haberer, J. (2020). Mobile Health Technologies May Be Acceptable Tools for Providing Social Support to Tuberculosis Patients in Rural Uganda: A Parallel Mixed-Method Study. Tuberculosis Research and Treatment. https://doi.org/10.1155/2020/7401045
Ngwatu, B., Nsengiyumva, N. P., Oxlade, O., Mappin-Kasirer, B., Nguyen, N. T. V, Jaramillo, E., Falzon, D., & Schwartzman, K. (2018). The Impact of Digital Health Technologies on Tuberculosis Treatment: A Systematic Review. European Respiratory Journal. https://doi.org/10.1183/13993003.01596-2017
Noviyani, A., Nopsopon, T., & Pongpirul, K. (2021). Variation of Tuberculosis Prevalence Across Diagnostic Approaches and Geographical Areas of Indonesia. Plos One. https://doi.org/10.1371/journal.pone.0258809
Park, J., Hong, Y., & Hong, J. Y. (2023). Risk for Multidrug-Resistant Tuberculosis in Patients Treated With Anti-Tumor Necrosis Factor Agents. Frontiers in Medicine. https://doi.org/10.3389/fmed.2023.1108119
Parwati, C. G., Farid, M. N., Nasution, H. S., Basri, C., Lolong, D. B., Gebhard, A., Tiemersma, E., Pambudi, I., Surya, A., & Houben, R. M. G. J. (2020). Estimation of Subnational Tuberculosis Burden: Generation and Application of a New Tool in Indonesia. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.19.0139
Priyandani, Y., Rahem, A., Djunaedi, Mup. I. A., Athiyah, U., Qomaruddin, M. B., & Kuntoro. (2019). Pharmacist’s Knowledge of Pulmonary Tuberculosis in a Cross Sectional Survey at Primary Health Care Centers in Surabaya, Indonesia. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.5958/0973-9130.2019.00522.x
Puspita, T., Suryatma, A., Simarmata, O. S., Veridona, G., Lestary, H., Athena, A., Pambudi, I., Sulistyo, S., & Pakasi, T. T. (2021). Spatial Variation of Tuberculosis Risk in Indonesia 2010-2019. Health Science Journal of Indonesia. https://doi.org/10.22435/hsji.v12i2.5467
Putri, O., Salim, M. A., Gunawan, A., Devin, D., Amaris, E., Alexander, D. M., Kevin, G., & Febriana, G. G. (2023). Drug-Resistant Pulmonary Tuberculosis. Indonesian Journal of Life Sciences. https://doi.org/10.54250/ijls.v5i01.172
Rachmawati, D. S., Nursalam, N., Hargono, R., Amin, M., & Damayanti, N. A. (2021). Individual-Level Factors Associated With Quality of Life Among TB Patients. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v15i3.15735
Samanta, S., Kumar, S., Aratikatla, E. K., Ghorpade, S. R., & Singh, V. (2023). Recent Developments of Imidazo[1,2-a]pyridine Analogues as Antituberculosis Agents. RSC Medicinal Chemistry. https://doi.org/10.1039/d3md00019b
Schunk, D. H., & DiBenedetto, M. K. (2020). Motivation and social cognitive theory. Contemporary Educational Psychology, 60, 101832.
Singh, R., Dwivedi, S. P., Gaharwar, U. S., Meena, R., Rajamani, P., & Prasad, T. (2019). Recent Updates on Drug Resistance In Mycobacterium Tuberculosis. Journal of Applied Microbiology. https://doi.org/10.1111/jam.14478
Sofiana, L., Ayu, S. M., Wardani, Y., Puspaningrum, E., & Hadianti, D. D. (2022). Risk Factors of Quality of Life Among Tuberculosis Patients. International Journal of Public Health Science (Ijphs). https://doi.org/10.11591/ijphs.v11i3.21005
Subbaraman, R., Mondesert, L. d., Musiimenta, A., Pai, M., Mayer, K. H., Thomas, B., & Haberer, J. (2018). Digital Adherence Technologies for the Management of Tuberculosis Therapy: Mapping the Landscape and Research Priorities. BMJ Global Health. https://doi.org/10.1136/bmjgh-2018-001018
Tadesse, A. W., Mohammed, Z., Foster, N., Quaife, M., McQuaid, C. F., Levy, J., Kalmthout, K. v., Rest, J. v., Jerene, D., Abdurhman, T., Yazew, H., Umeta, D. G., Assefa, D., Weldemichael, G. T., Bedru, A., Letta, T., & Fielding, K. (2021). Evaluation of Implementation and Effectiveness of Digital Adherence Technology With Differentiated Care to Support Tuberculosis Treatment Adherence and Improve Treatment Outcomes in Ethiopia: A Study Protocol for a Cluster Randomised Trial. BMC Infectious Diseases. https://doi.org/10.1186/s12879-021-06833-x
Thomas, B., Kumar, J., Nagarajan, K., Khandewale, A. S., Mercy, J. H., Raj, E. M., Kokila, S., Walgude, A. S., Gaurkhede, G. R., Kumbhar, J. D., Ovung, S., Paul, M., Rajkumar, B. S., & Subbaraman, R. (2021). Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers. Journal of Medical Internet Research. https://doi.org/10.2196/23294
Thomas, B., Kumar, J., Onongaya, C., Bhatt, S. N., Galivanche, A., Nagarajan, K., Chiranjeevi, M., Khandewale, A. S., Ramachandran, G., Shah, D., Haberer, J., Mayer, K. H., & Subbaraman, R. (2020). Explaining Differences in the Acceptability of 99DOTS, a Cell Phone–Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers. Jmir Mhealth and Uhealth. https://doi.org/10.2196/16634
Touré, A. A., Magassouba, A. S., Camara, G. N. N. L., Doumbouya, A., Cissé, D., Barry, I., Camara, L. M., Beavogui, A. H., Delamou, A., Veronese, V., Merle, C., Traoré, H. A., & Bangoura, A. M. (2022). Health-Related Quality of Life of Tuberculosis Patients During the COVID-19 Pandemic in Conakry, Guinea: A Mixed Methods Study. https://doi.org/10.20944/preprints202207.0351.v1
Travedi, P. (2023). Implementation of Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD) for Improving Treatment Adherence Amongst Drug-Resistant Tuberculosis Patients in Ahmedabad City, Gujarat. https://doi.org/10.1101/2023.10.18.23297189
Vaz, C., Jose, N. K., Tom, J. J., Goodman, G. R., Lee, J. S., Padappayil, R. P., Madathil, M., O’Cleirigh, C., Rodrigues, R., & Chai, P. R. (2022). Formative Acceptance of Ingestible Biosensors to Measure Adherence to TB Medications: An Exploratory Study. https://doi.org/10.21203/rs.3.rs-1727814/v1
Veronese, V., Miller, C., Ogundahunsi, O., Boon, S. d., Xia, Y., Falzon, D., & Merle, C. (2023). A New Online Toolkit to Support Implementation Research to Enhance the Use of Digital Innovations to End TB. Plos Digital Health. https://doi.org/10.1371/journal.pdig.0000182
WHO. (2017). WHO | Commission on Social Determinants of Health - final report. Who, 247. http://www.who.int/social_determinants/thecommission/finalreport/en/
Xie, Y., Zhang, Z., Zhang, M., & Cao, H. (2022). Cofilin 1 as a Potential Biomarker for Mycobacterium tuberculosis Infection. Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2022.11178
Yohannes, K., Mokona, H., Abebe, L., Feyisso, M., Tesfaye, A., Tesfaw, G., & Ayano, G. (2020). Prevalence of Depressive Symptoms and Associated Factors Among Patients With Tuberculosis Attending Public Health Institutions in Gede’o Zone, South Ethiopia. BMC Public Health. https://doi.org/10.1186/s12889-020-09794-z
Zhang, C., Zhao, F., Xia, Y., Yu, Y., Shen, X., Lu, W., Wang, X., Jin, X., Ye, J., Li, J., Liu, F.-Y., Wu, J., Xu, L., Zhang, H., Cheng, J., & Wang, L. (2019). Prevalence and Risk Factors of Active Pulmonary Tuberculosis Among Elderly People in China: A Population Based Cross-Sectional Study. Infectious Diseases of Poverty. https://doi.org/10.1186/s40249-019-0515-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ahmar Metastasis Health Journal
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
